Molecule Details
| InChIKey | BGEBZHIAGXMEMV-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | COc1c2ccoc2cc2oc(=O)ccc12 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.15 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12216 |
|---|---|
| Drug Name | Bergapten |
| CAS Number | 484-20-8 |
| Groups | investigational |
| ATC Codes | D05BA03 |
| Description | Bergapten is under investigation in clinical trial NCT00533195 (Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis). |
Categories: Anti-Inflammatory Agents Antipsoriatics Antipsoriatics for Systemic Use Benzopyrans Coumarins Dermatologicals Furocoumarins Heterocyclic Compounds, Fused-Ring Photosensitizing Agents Photosensitizing Agents for Phototherapy Psoralens for Systemic Use Pyrans Radiation-Sensitizing Agents
Cross-references: BindingDB: 50067880 ChEBI: 18293 CHEMBL24171 ChemSpider: 2265 C01557 PubChem:2355 PubChem:347828496 RxCUI: 15842 Wikipedia: Bergapten ZINC: ZINC000000057731